COMPANY
COMPANY
The drug candidates to increase the success rate Leading Research and Development company for the discovery of optimal novel drug candidates and repurposing of novel drugs using orthotopic model-based clinical translational research
- Company name
- PLATBIO Inc.
- CEO
- KIM SUN JIN
- Est.
- 2018.08.03.
- Major business
- New drug R&D/ Consulting/ Research service
- Head office
- #1501, Ace Gwanggyo Tower 2, 91, Changnyong-daero 256 beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea
- Homepage
- www.platbio.com
-
Orthotopic Animal Model,
Clinical Translational Research Orthotopic Animal Model & Clinical Translational Research Enabling accurate pre-clinical trials with world class orthotopic model and clinical translational research capability -
Increasing the
Success Rate of
Clinical Trials Higher success rate of
clinical trials from scientifically
accurate pre-clinical data -
Largest Number of Novel Anticancer Targets
in Korea50 novel targets from pancreatic
cancer and ovarian cancer and expanding the target list from other indications -
Global
NetworkBroad and Deep connections with global big pharmas to enable bigger license- out deals